Benvimod is a synthetic natural product for the treatment of psoriasis. The research history of Benvimod began in 1999, and Chen Genghui's team obtained the patent of Benvimod. This is a small molecular compound isolated from the metabolite of a symbiotic bacterium of soil nematodes. Follow-up studies found that benvimod can treat inflammatory and autoimmune diseases, and it is the first therapeutic aromatic hydrocarbon receptor modulator (TAMA), which has a brand-new mechanism of action and can inhibit the pathogenesis of psoriasis in multiple ways. At present, four synthetic routes of Benvimod have been reported, all of which have their own disadvantages, so it is of great significance to find a green and efficient synthetic route. This project plans to develop efficient green synthesis technology of Benvimod based on Heck reaction to shorten the steps of synthesis route.
正在翻译中..